Profound Medical Corp.
NASDAQ:PROF · NASDAQ Capital Market
+$0.27 today
Vol 0.09M · Avg 0.12M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+14.31%
Period High
$8.65
Period Low
$3.87
Latest
$6.87
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Anteris Technologies Global Corp.
NASDAQ:AVR
$348.20M
Prenetics Global Limited
NASDAQ:PRE
$343.75M
Armata Pharmaceuticals, Inc.
AMEX:ARMP
$258.44M
Perspective Therapeutics, Inc.
AMEX:CATX
$232.14M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$147.66M
MaxCyte, Inc.
NASDAQ:MXCT
$125.90M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$119.35M
Owlet, Inc.
NYSE:OWLT
$90.11M
Neuronetics, Inc.
NASDAQ:STIM
$84.61M
LENSAR, Inc.
NASDAQ:LNSR
$71.05M
What is the latest PROF filing?
The latest filing shown is EFFECT dated May 19, 2026.
How many recent filings does PROF have?
Intrinsic Alpha currently shows 20 recent filings for PROF.
Explore More
Continue the stock analysis
Jump to another research area for this company.